A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients

Objectives: To assess whether the histopathological features of the synovium before starting treatment with the TNFi certolizumab-pegol could predict clinical outcome and examine the modulation of histopathology by treatment. Methods: Thirty-seven RA patients fulfilling UK NICE guidelines for biolog...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Autores principales: Nerviani, Alessandra, Di Cicco, Maria, Mahto, Arti, Lliso-Ribera, Gloria, Rivellese, Felice, Thorborn, Georgina, Hands, Rebecca, Bellan, Mattia, Mauro, Daniele, Boutet, Marie-Astrid, Giorli, Giovanni, Lewis, Myles, Kelly, Stephen, Bombardieri, Michele, Humby, Frances, Pitzalis, Costantino
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7214807/
https://ncbi.nlm.nih.gov/pubmed/32431716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00845
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares